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Abstract  
AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly 
Drugs Resistance (XDR) category to anti-pseudomonas drugs.  
MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in 
large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was 
carried out by disk method and the serial dilution method with the interpretation of the results 
according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES 
classes was carried out by PCR method using the commercial kits.  
RESULTS: All identified carbapenemases were sorted to VIM class and accounted for 63.64%. 
Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.  
CONCLUSION: Thus, at the present stage the circulation of P. aeruginosa strains of XDR category 
continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin.
 
 
 
 
 
 
 
Introduction 
 
 Antibiotic resistance as a phenomenon of 
microorganisms' insensibility to achievable 
concentrations of antibiotics in clinical conditions has 
become in the last 20 years the pattern of the global 
problem, migrated from the level of individual 
departments and hospitals to the level of a global 
epidemic process, threatening the future of humanity. 
Every year more than 20 thousand patients 
die in the USA in the result of infectious processes 
caused by multidrug-resistant microorganisms. The 
USA government spends more than 20 billion dollars 
a year for the control of antibiotic-resistant strains 
spreading [1].
 
The EU countries annually spend more than 9 
billion euros for the solution of the problem. At the 
same time in the European Union more than 25 
thousand patients a year die because of ineffective 
antimicrobial chemotherapy, and more than half of the 
cases caused by Gram-negative microorganisms [2]. 
The last in most cases have multidrug resistance 
mechanisms, leading to a significant narrowing of the 
list of choice drugs and in the cases of pan-resistance 
– to almost no alternative solutions [3]. 
Till recently carbapenems were regarded as 
the drugs of extreme selection. However wide 
spreading of carbapenemases genes significantly 
expanded the list of problematic strains in which of 
Pseudomonas aeruginosa is regarded as a classic 
representative [4]. Modern strains of P. aeruginosa in 
addition to many natural mechanisms and 
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antimicrobial resistance mechanisms due to the high 
genetic lability constantly replenish its arsenal of 
acquired resistance mechanisms [5] and have the 
predilection to the clonal global spreading [6]. From 
this perspective, the continuous supervision for the 
local spread of multidrug-resistant strains is important 
for practical health care as well as for fundamental 
science. The strains of XDR (eXtremaly Drugs 
Resistance) category [7] are the particular problem for 
medicine because of extreme multi-resistance to a 
wide range of antimicrobial agents.
 
Our study focuses on the description of the 
sensitivity of antimicrobial agents and detection of 
genes that determine resistance to carbapenems in of 
P. aeruginosa strains of XDR category, isolated in 
large hospitals of Central Kazakhstan. 
 
 
Materials and Methods 
 
The study included strains collected in the 
period from 2015 to 2016 during the prospective 
multicenter microbiological research covering large 
multidisciplinary hospitals of Central Kazakhstan 
(Karaganda and Astana). 
Isolation of strains was conducted in local 
bacteriological laboratories of participating centres, 
and after the strains were forwarded to the 
microbiology laboratory of the Scientific-Research 
Center of Karaganda State Medical University, where 
it was conducted the re-identification methods of time-
of-flight mass-spectrometry (MALDI-TOF) using 
MALDI-Biotyper software (Bruker). Determination of 
sensitivity to antimicrobial agents was conducted by 
disk- diffusion method and by the method of serial 
microdilution in a liquid medium according to EUCAST 
recommendations [8].
 
The primary test for detection of Metallo-beta-
lactamase activity was carried out with 100 mM EDTA 
by the recommendations [9]. Additional screening CIM 
test for detection of carbapenemases activity was 
carried out by the recommendations [10].
 
The presence of carbapenemases genes of 
VIM and IMP classes were performed by Real-Time 
PCR methods using the commercial kit «AmpliSens 
MDR MBL-FL» produced by Interlab Service (Russia). 
Statistical processing was performed by 
determining the average values, the definition of rank 
correlation coefficient by Spearman and determining 
the 95% confidence interval for the mean values by 
Klopper-Pearson with the use of MS Excel and 
Whonet 6.5 [11]. 
 
 
Results 
 
As a result of screening, it was selected 37 
strains with XDR phenotypic profile among 270 strains 
collected in large multidisciplinary hospitals of Central 
Kazakhstan. 
Data on antimicrobial resistance is shown in 
Figure 1. 
 
Figure 1: The share of non-sensitive (%R+%I) hospital P. 
aeruginosa strains to antimicrobial drugs. The dotted squares 
represent 95% confidence intervals 
 
The studied strains were characterised by 
resistance to the absolute majority of drugs with anti-
pseudomonas activity. The exception was polymyxin, 
to which we did not reveal any resistant strain. Taking 
into account the trend towards the emergence of 
resistant strains of P. aeruginosa to colistin [12] we 
carried out a quantitative evaluation of the sensitivity 
of the studied strains to polymyxin. 
MIC50 for studied strains was 0.5 µg/ml but 
MIC range was 0.5-2 µg/ml. This pattern suggests 
polymyxin as the only available anti-pseudomonas 
drug with high activity, and it actualizes the questions 
on the development of technologies increasing the 
bioavailability of the drug [13]. Sensitivity to 
aztreonam was observed in more than half of the 
cases (51.43%; 95% CI, 31.25-71.15). A similar 
pattern is due to the high frequency of occurrence of 
strains producing Metallo-beta-lactamase (B class) 
hydrolyzing all beta-lactams except aztreonam [14], 
which proportion was 68.75%. 
Genetic typing of the mechanisms of 
resistance to carbapenems identified the 
carbapenemases genes of VIM class, the proportion 
of strains producing carbapenemases of VIM class 
was 63.64% (95% CI 39.63-81.17). Meanwhile, the 
test with chelating agent EDTA showed inhibitory 
activity in 31 strains that in combination with MIC 
values corresponding to the expected moderate 
stability permit to expect the low-affinity 
carbapenemases of GES class. However, conducted 
research has not revealed GES carbapenemases 
genes. Ecoff analysis of distributions on imipenem 
(Fig. 2) allows surmising sampling heterogeneity. 
According to that 75% isolates have MIC 
higher 32 µg/ml we expected an equal number of 
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producers of carbapenemases. At the same time, 
PCR detection of VIM producers was positive in 
63.64% which is clearly linked to other mechanisms of 
resistance. Strains with moderate resistance 
imipenem were moderately resistant to meropenem 
and also to aminoglycosides that can be connected 
with other on- enzymatic resistance mechanisms 
[15].
 
 
Figure 2: Ecoff distribution of MIC imipenem for studied P. 
aeruginosa strains (boundary values 4-16 µg/ml), S – sensitive 
population, I – moderately resistant, R – resistant population 
 
Resistance to fluorinated quinolones was 
detected in more than 90%, the average MIC values 
were extremely high too (>32 µg/ml). Resistance to 
ciprofloxacin had a strong positive correlation with 
resistance to levofloxacin, which is obviously 
connected with the general resistance mechanisms 
and can approximate these results to the whole group 
of fluorinated quinolones. 
 
 
Discussion 
 
At present the only drug with a high-clinically 
significant activity against studied pan-resistant P. 
aeruginosa strains is polymyxin. We did not reveal 
any cases of resistance; all the studied strains had 
MIC less than 1 µg/ml. The average values of the MIC 
of polymyxin totalled 0.49 µg/ml.
 
The resulting picture clearly shows that there 
is no alternative situation on the choice of drugs for 
the causal treatment of infections caused by 
extremely resistant P. aeruginosa strains. 
Thus, at the present stage, the circulation of 
P. aeruginosa strains of XDR category continues in 
major hospitals in Kazakhstan, which have been 
shown previously [16]. The strains remain 
sensitiveness only to polymyxin. 
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